+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
MALE
ID06771843

Kisoboka Study to Reduce Hazardous Alcohol Use and Improve HIV Treatment Among Men in Fishing Communities

Led by San Diego State University · Updated on 2026-05-12

716

Participants Needed

1

Research Sites

17 weeks

Total Duration

AI-Summary

What this Trial Is About

Researchers are evaluating the Kisoboka intervention to help men living with HIV in fishing communities reduce hazardous alcohol use, improve adherence to HIV medications, and achieve undetectable HIV viral loads. These communities face unique social and structural challenges, including prevalent drinking norms, stressful work, and economic factors that contribute to high alcohol misuse and poor HIV outcomes. The study compares Kisoboka to other behavioral approaches to optimize treatment as prevention among men who drink at hazardous levels. The study includes several intervention groups Kisoboka, Behavioral Economics, Motivational Interviewing, and Screening and Referral. Kisoboka combines financial goal setting, text reminders, substance-free activities, mobile money use, social support, and motivational counseling to reduce alcohol use and improve medication adherence. Participants attend 1 to 6 counseling sessions over 1 to 16 weeks, which can be individual or group sessions, depending on their assigned study arm. Participants will be monitored through assessments at baseline, 6, and 12 months to measure changes in alcohol use via Phosphatidylethanol levels, hazardous drinking status, ART adherence, and HIV viral loads. Secondary measures include depressive symptoms, physical health, self-reported adherence, and food security. The study uses random assignment and double masking to compare outcomes. Participants must have access to a mobile phone and remain in the community during the study period, with follow-up visits to track progress and safety.

CONDITIONS

Brief Title

Reducing Hazardous Alcohol Use and Optimizing Treatment as Prevention Among Men Living With HIV in Risk Environments

Research Team

J

Joseph Matovu, PhD, MHS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here